Cargando…

Effects of wogonoside on the inflammatory response and oxidative stress in mice with nonalcoholic fatty liver disease

CONTEXT: Wogonoside has many pharmacological activities, but whether it has a protective effect against non-alcoholic fatty liver disease (NAFLD) has not been reported. OBJECTIVE: This study investigates the protective effect of wogonoside against NAFLD in mice and its potential mechanism. MATERIALS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Guangyu, Chen, Dayin, Li, Wenpeng, Liu, Chengcheng, Liu, Jiguang, Guo, Yingxue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875554/ https://www.ncbi.nlm.nih.gov/pubmed/33253604 http://dx.doi.org/10.1080/13880209.2020.1845747

Ejemplares similares

Rimonabant Improves Oxidative/Nitrosative Stress in Mice with Nonalcoholic Fatty Liver Disease
por: Jorgačević, Bojan, et al.
Publicado: (2015)

Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
por: Masarone, Mario, et al.
Publicado: (2018)

Oxidative Stress and Nonalcoholic Fatty Liver Disease in Hemodialysis Patients
por: Wu, Po-Jung, et al.
Publicado: (2018)

Mechanism in the existent difference in form of wogonin/wogonoside between plasma and intestine/liver in rats
por: Wang, Qian, et al.
Publicado: (2018)

Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
por: Wang, Xin, et al.
Publicado: (2011)

Reduced Glutathione suppresses Oxidative Stress in Nonalcoholic Fatty Liver Disease
por: Irie, Makoto, et al.
Publicado: (2016)

Corrigendum to “Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease”
por: Masarone, Mario, et al.
Publicado: (2021)

Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress
por: Ji, Yun, et al.
Publicado: (2019)

Hepatoprotective effect of calculus bovis sativus on nonalcoholic fatty liver disease in mice by inhibiting oxidative stress and apoptosis of hepatocytes
por: He, Wenxi, et al.
Publicado: (2017)

Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease
por: Ma, Yuanqiang, et al.
Publicado: (2021)

Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease
por: Mukai, Takako, et al.
Publicado: (2017)

Hepatic transcriptome signatures in mice and humans with nonalcoholic fatty liver disease
por: Ding, Yiming, et al.
Publicado: (2023)

Therapeutic efficacy of polydatin for nonalcoholic fatty liver disease via regulating inflammatory response in obese mice
por: Mo, Juan-Fen, et al.
Publicado: (2018)

Nobiletin Intake Attenuates Hepatic Lipid Profiling and Oxidative Stress in HFD-Induced Nonalcoholic-Fatty-Liver-Disease Mice
por: Ke, Zunli, et al.
Publicado: (2023)

Effects of wogonoside on invasion and migration of lung cancer A549 cells and angiogenesis in xenograft tumors of nude mice
por: Yan, Yubo, et al.
Publicado: (2020)

Wogonoside induces depalmitoylation and translocation of PLSCR1 and N‐RAS in primary acute myeloid leukaemia cells
por: Li, Hui, et al.
Publicado: (2018)

Treatment of Brain Edema by Wogonoside Is Associated with Inhibition of Neuronal Apoptosis and SIRT1 Activation in Rats
por: Cheng, Yingqiu, et al.
Publicado: (2020)

The Relationship between Intestinal Motility and Interstitial Cells of Cajal in Nonalcoholic Fatty Liver Mice
por: Lu, Ming-Liang, et al.
Publicado: (2013)

Wogonoside promotes apoptosis and ER stress in human gastric cancer cells by regulating the IRE1α pathway
por: Gu, Qian, et al.
Publicado: (2021)

Protective effect of Monarda didymaL. essential oil and its main component thymol on learning and memory impairment in aging mice
por: Guo, Yingxue, et al.
Publicado: (2022)

Wogonoside inhibits inflammatory cytokine production in lipopolysaccharide-stimulated macrophage by suppressing the activation of the JNK/c-Jun signaling pathway
por: Yu, Xiu, et al.
Publicado: (2020)

Wogonoside inhibits invasion and migration through suppressing TRAF2/4 expression in breast cancer
por: Yao, Yuyuan, et al.
Publicado: (2017)

The improvement of Coreopsis tinctoria essential oil on learning and memory impairment of d-galactose-induced mice through Nrf2/NF-κB pathway
por: Qu, Yan, et al.
Publicado: (2022)

OSAS-Related Inflammatory Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
por: Paschetta, Elena, et al.
Publicado: (2015)

Lycium ruthenicum Murr. alleviates nonalcoholic fatty liver in mice
por: Lu, Keke, et al.
Publicado: (2020)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
por: Niu, Shu, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD)
por: Gonzalez, Andrea, et al.
Publicado: (2020)

Status of Essential Trace Minerals and Oxidative Stress in Viral Hepatitis C Patients with Nonalcoholic Fatty Liver Disease
por: Guo, Chih-Hung, et al.
Publicado: (2013)

Pretreatment of baicalin and wogonoside with glycoside hydrolase: A promising approach to enhance anticancer potential
por: YU, CHUNHAO, et al.
Publicado: (2013)

Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice
por: Rom, Oren, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk
por: Barbarroja, Nuria, et al.
Publicado: (2022)

Recent evaluation about inflammatory mechanisms in nonalcoholic fatty liver disease
por: Song, Chong, et al.
Publicado: (2023)

Update on Berberine in Nonalcoholic Fatty Liver Disease
por: Liu, Yang, et al.
Publicado: (2013)

Correction to: Wogonoside inhibits invasion and migration through suppressing TRAF2/4 expression in breast cancer
por: Yao, Yuyuan, et al.
Publicado: (2019)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Lipoprotein metabolism in nonalcoholic fatty liver disease
por: Jiang, Zhenghui Gordon, et al.
Publicado: (2013)

The Role of Bone Morphogenetic Protein 9 in Nonalcoholic Fatty Liver Disease in Mice
por: Sun, Qin-Juan, et al.
Publicado: (2021)

The role of complement in nonalcoholic fatty liver disease
por: Guo, Zhenya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mfnnlqepalselbbl5ufmea2vfn